Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Mesenchymal stromal cell therapy for Crohn's disease.

Liew A, O'Brien T, Egan L.

Dig Dis. 2014;32 Suppl 1:50-60. doi: 10.1159/000367826. Epub 2014 Dec 17.

PMID:
25531353
2.

Hypercalcaemic hyperparathyroid crisis.

Linane H, Egan AM, Griffin TP, Quill D, Phelan SM, O'Brien T.

QJM. 2014 Dec 17. pii: hcu245. [Epub ahead of print] No abstract available.

PMID:
25524907
3.

Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat.

Hayes M, Masterson C, Devaney J, Barry F, Elliman S, O'Brien T, O'Toole D, Curley GF, Laffey JG.

Anesthesiology. 2015 Feb;122(2):363-73. doi: 10.1097/ALN.0000000000000545.

PMID:
25490744
4.

Glycaemic control is harder to achieve than blood pressure or lipid control in Irish adults with type 1 diabetes.

Cotter TG, Dinneen SF, Healy DA, Bell MJ, Cunningham A, O'Shea PM, Dunne F, O'Brien T, Finucane FM.

Diabetes Res Clin Pract. 2014 Dec;106(3):e56-9. doi: 10.1016/j.diabres.2014.09.036. Epub 2014 Oct 5.

PMID:
25451911
5.

Aerosol-mediated delivery of AAV2/6-IκBα attenuates lipopolysaccharide-induced acute lung injury in rats.

MacLoughlin RJ, Higgins BD, Devaney J, O'Toole D, Laffey JG, O'Brien T.

Hum Gene Ther. 2015 Jan;26(1):36-46. doi: 10.1089/hum.2014.053.

PMID:
25382145
6.

MSCs isolated from patients with ischemic vascular disease have normal angiogenic potential.

Sanz-Nogués C, O'Brien T.

Mol Ther. 2014 Nov;22(11):1888-9. doi: 10.1038/mt.2014.191. No abstract available.

PMID:
25365987
7.

A shape-controlled tuneable microgel platform to modulate angiogenic paracrine responses in stem cells.

Thomas D, Fontana G, Chen X, Sanz-Nogués C, Zeugolis DI, Dockery P, O'Brien T, Pandit A.

Biomaterials. 2014 Oct;35(31):8757-66. doi: 10.1016/j.biomaterials.2014.06.053. Epub 2014 Jul 18.

PMID:
25047627
8.

Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.

Davey GC, Patil SB, O'Loughlin A, O'Brien T.

Front Endocrinol (Lausanne). 2014 Jun 6;5:86. doi: 10.3389/fendo.2014.00086. eCollection 2014. Review.

9.

The potential of cell-based therapy for diabetes and diabetes-related vascular complications.

Liew A, O'Brien T.

Curr Diab Rep. 2014 Mar;14(3):469. doi: 10.1007/s11892-013-0469-6. Review.

PMID:
24464340
10.

Use of a fibrin-based system for enhancing angiogenesis and modulating inflammation in the treatment of hyperglycemic wounds.

Kulkarni M, O'Loughlin A, Vazquez R, Mashayekhi K, Rooney P, Greiser U, O'Toole E, O'Brien T, Malagon MM, Pandit A.

Biomaterials. 2014 Feb;35(6):2001-10. doi: 10.1016/j.biomaterials.2013.11.003. Epub 2013 Dec 10.

PMID:
24331702
11.

Mesenchymal stem cell survival in the infarcted heart is enhanced by lentivirus vector-mediated heat shock protein 27 expression.

McGinley LM, McMahon J, Stocca A, Duffy A, Flynn A, O'Toole D, O'Brien T.

Hum Gene Ther. 2013 Oct;24(10):840-51. doi: 10.1089/hum.2011.009.

12.

Robust, efficient, and practical electrogene transfer method for human mesenchymal stem cells using square electric pulses.

Liew A, André FM, Lesueur LL, De Ménorval MA, O'Brien T, Mir LM.

Hum Gene Ther Methods. 2013 Oct;24(5):289-97. doi: 10.1089/hgtb.2012.159. Epub 2013 Aug 30.

13.

Restructuring of the Diabetes Day Centre: a pilot lean project in a tertiary referral centre in the West of Ireland.

McDermott AM, Kidd P, Gately M, Casey R, Burke H, O'Donnell P, Kirrane F, Dinneen SF, O'Brien T.

BMJ Qual Saf. 2013 Aug;22(8):681-8. doi: 10.1136/bmjqs-2012-001676. Epub 2013 May 30.

PMID:
23722055
14.

Impact of mesenchymal stem cell secreted PAI-1 on colon cancer cell migration and proliferation.

Hogan NM, Joyce MR, Murphy JM, Barry FP, O'Brien T, Kerin MJ, Dwyer RM.

Biochem Biophys Res Commun. 2013 Jun 14;435(4):574-9. doi: 10.1016/j.bbrc.2013.05.013. Epub 2013 May 16.

PMID:
23685140
15.

Gene therapy for type 1 diabetes moves a step closer to reality.

O'Brien T.

Diabetes. 2013 May;62(5):1396-7. doi: 10.2337/db13-0348. No abstract available.

16.

Topical administration of allogeneic mesenchymal stromal cells seeded in a collagen scaffold augments wound healing and increases angiogenesis in the diabetic rabbit ulcer.

O'Loughlin A, Kulkarni M, Creane M, Vaughan EE, Mooney E, Shaw G, Murphy M, Dockery P, Pandit A, O'Brien T.

Diabetes. 2013 Jul;62(7):2588-94. doi: 10.2337/db12-1822. Epub 2013 Feb 19.

17.

Radiological remission and recovery of thirst appreciation after infliximab therapy in adipsic diabetes insipidus secondary to neurosarcoidosis.

O'Reilly MW, Sexton DJ, Dennedy MC, Counihan TJ, Finucane FM, O'Brien T, O'Regan AW.

QJM. 2013 Feb 14. [Epub ahead of print]

PMID:
23417911
18.

Liposomal surface coatings of metal stents for efficient non-viral gene delivery to the injured vasculature.

Ganly S, Hynes SO, Sharif F, Aied A, Barron V, McCullagh K, McMahon J, McHugh P, Crowley J, Wang W, O'Brien T, Greiser U.

J Control Release. 2013 Apr 28;167(2):109-19. doi: 10.1016/j.jconrel.2013.01.036. Epub 2013 Feb 10.

PMID:
23403396
19.

Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury.

Curley GF, Ansari B, Hayes M, Devaney J, Masterson C, Ryan A, Barry F, O'Brien T, Toole DO, Laffey JG.

Anesthesiology. 2013 Apr;118(4):924-32. doi: 10.1097/ALN.0b013e318287ba08.

PMID:
23377221
20.

The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.

Mulcahy P, O'Doherty A, Paucard A, O'Brien T, Kirik D, Dowd E.

Behav Brain Res. 2013 Apr 15;243:6-15. doi: 10.1016/j.bbr.2012.12.051. Epub 2013 Jan 4.

PMID:
23295396
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk